Compare Stocks › BAC vs CVS

Bank of America Corporation (BAC) vs CVS Health Corporation (CVS): Which Is the Better Buy in 2026?

As of 2026-11-01, BAC is undervalued at $50, with a DCF intrinsic value of $180 and a margin of safety of 72%. CVS is overvalued at $90, with an intrinsic value of $5 and a margin of safety of -1592%. Of the two, BAC has the wider margin of safety.

BAC
Bank of America Corporation
$50.01
VS
CVS
CVS Health Corporation
$90.25

Rewards

BAC
  • ★Bank of America Corporation scores 100/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • ★PEG ratio of 0.91 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.
CVS
  • ★Management has timed buybacks well — 2 out of 3 years showed value-accretive repurchases.
  • ★PEG ratio of 0.21 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.

Risks

BAC
  • ⚠Gross margin of 0.0% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • ⚠Altman Z-Score of 0.22 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
CVS
  • ⚠Gross margin of 13.6% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • ⚠FCF yield of 7.0% suggests reasonable valuation assuming continued moderate growth.
  • ⚠Free cash flow has declined at a 16.6% CAGR over the past 4 years — a concerning trend.

Key Valuation Metrics

Learn more →
BAC
CVS
Valuation
N/A
Free Cash Flow
$8.08B
N/A
FCF Yield
7.00%
11.94
Trailing P/E
23.75
9.64
Forward P/E
10.57
Quality & Moat
3.80%
ROIC
8.06%
10.73%
ROE
6.21%
0.00%
Gross Margin
13.65%
0.91
PEG Ratio
0.21
Balance Sheet Safety
N/A
Net Debt / Equity
0.78
N/A
Interest Coverage
N/A
N/A
Net Debt / EBITDA
3.74
2.56%
Dividend Yield
2.95%
BAC: 3Ties: 1CVS: 4
BACCVS

Historical Fundamentals

Learn more →
BAC

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

CVS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
BAC
$2.37
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$55.63B
Δ Market Cap
+$131.83B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
CVS
$-4.20
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$4.82B
Δ Market Cap
$-20.28B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
BAC
72.2% Margin of Safety
Price is 72.2% below estimated fair value
Current Price: $50.01
Fair Value: $180.08
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
CVS
1592.5% Overvalued
Price is 1592.5% above estimated fair value
Current Price: $90.25
Fair Value: $5.33
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
BAC

Requires positive FCF to compute implied growth rate.

CVS

What growth rate is the market pricing in at $90?

+20.3%
Market-Implied Owner Earnings Growth
Standard FCF implies +9.0%

The market implies +20.3% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +9.0%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
BAC
100/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Reinvestment Efficiency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
CVS
49/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
BAC
-2.31
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
CVS
-2.54
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
BAC
Insiders 7.1%Institutions 71.9%Retail & Other 21.0%
No. of Institutional Holders4,517
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
CVS
Insiders 0.1%Institutions 91.0%Retail & Other 8.9%
No. of Institutional Holders2,630
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
BAC
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
CVS
0
Buys (3M)
0
Buys (12M)
SANSONE GUY P
Director
$100,009
@ $63.70 · 2025-06-05
MAHONEY MICHAEL F
Director
$2.00M
@ $66.70 · 2025-02-18
NELSON STEVEN H
Officer
$1,289
@ $53.71 · 2025-01-23
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
BAC
0
Sells (3M)
5
Sells (12M)
Total value (12M): $20.17M
MENSAH BERNARD AMPONSAH
Officer
$4.41M
@ $46.94 · 2026-03-12
SCRIVENER THOMAS M
Officer
$2.49M
@ $49.82 · 2026-03-05
BRONSTEIN SHERI B
Officer
$2.99M
@ $49.91 · 2026-03-05
ATHANASIA DEAN C
President
$6.86M
@ $50.21 · 2026-03-03
BORTHWICK ALASTAIR M.
Chief Financial Officer
$3.42M
@ $50.24 · 2026-02-27
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
CVS
0
Sells (3M)
1
Sells (12M)
Total value (12M): $6.23M
MANDADI TILAK
Officer
$6.23M
@ $89.58 · 2026-05-08
CLARK JAMES DAVID
Officer
$498,488
@ $66.35 · 2025-03-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
BAC
FearGreed
😨Fear(39/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
CVS
FearGreed
😐Neutral(54/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
BAC
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (39)
CVS
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (54)
View BAC Full AnalysisView CVS Full Analysis

Frequently Asked Questions: BAC vs CVS

Is Bank of America Corporation or CVS Health Corporation more undervalued in 2026?▼

Based on our discounted cash flow model, BAC trades at a 72.2% margin of safety (intrinsic value $180 vs. price $50), compared to CVS's -1592.5% margin of safety (intrinsic $5 vs. $90).

Which stock has a wider economic moat, Bank of America Corporation or CVS Health Corporation?▼

BAC scores 100/100 (Wide moat), while CVS scores 49/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Bank of America Corporation in financial distress?▼

BAC's Altman Z-Score of 0.2 places it in the Distress zone, signaling elevated bankruptcy risk. CVS scores 2.3 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Bank of America Corporation or CVS Health Corporation?▼

CVS earns 8.1% ROIC versus BAC's 3.8%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Bank of America Corporation's or CVS Health Corporation's?▼

BAC's dividend earns a safety score of 79/100 (Safe), compared to CVS's 45/100 (Borderline). BAC has raised its dividend for 3 consecutive years.

BAC vs CVS: Which Is the Better Buy in 2026? | SafetyMargin.io